Medicare Benefit Policy Manual (Pub. 100-02), Ch. 15 § 80.1

Clinical Laboratory Services

Last amended: 2007Year: 2007Length: 174 wordsOfficial source
80.1 - Clinical Laboratory Services (Rev. 79; Issued: 10-19-07; Effective: 01-01-03; Implementation: 11-19-07) Section 1833 and 1861 of the Act provides for payment of clinical laboratory services under Medicare Part B. Clinical laboratory services involve the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition. Laboratory services must meet all applicable requirements of the Clinical Laboratory Improvement Amendments of 1988 (CLIA), as set forth at 42 CFR part 493. Section 1862(a)(1)(A) of the Act provides that Medicare payment may not be made for services that are not reasonable and necessary. Clinical laboratory services must be ordered and used promptly by the physician who is treating the beneficiary as described in 42 CFR 410.32(a), or by a qualified nonphysician practitioner, as described in 42 CFR 410.32(a)(3). See section 80.6 of this manual for related physician ordering instructions. See the Medicare Claims Processing Manual Chapter 16 for related claims processing instructions.
Medicare Benefit Policy Manual (Pub. 100-02), Ch. 15 § 80.1: Clinical Laboratory Services | Justis AI